Hao Zhang, PhD, is an experienced professional in the field of immunoassay method development, validation, and sample analysis in support of drug development. His expertise focuses on the Ligand Binding Assay (LBA) on ELISA and MSD platforms in a regulated environment. He has over 5 years of experience working on method development and validation of PK, Immunogenicity (ADA, Nab), and Biomarkers. In his role at Acumen, he develops highly specific and sensitive immunoassays for measuring biologic molecules in various matrices in partnership with vendors and oversees Contract Research Organizations (CROs) as a scientific liaison and Subject Matter Expert (SME).

Prior to joining Acumen, Dr. Zhang worked as Principal Investigator and Lead Scientist at LabCorp responsible for developing and validating PK and immunogenicity assays under GLP regulations to support preclinical and clinical studies.

Zhang earned his PhD in Molecular Immunology from Academy of Military Medical Sciences, China and was a postdoctoral fellow in the program of Molecular Therapeutics at Fox Chase Cancer Center, Temple University.